Global Nicardipine Hydrochloride Injection Market Growth 2020-2025
According to this study, over the next five years the Nicardipine Hydrochloride Injection market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nicardipine Hydrochloride Injection business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nicardipine Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Nicardipine Hydrochloride Injection, covering the supply chain analysis, impact assessment to the Nicardipine Hydrochloride Injection market size growth rate in several scenarios, and the measures to be undertaken by Nicardipine Hydrochloride Injection companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
20 mg / 200 mL
40 mg / 200 mL
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Recovery Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
Teva
Hikma
Sun Pharma
Chiesi
Mylan
Sandoz
Wockhardt
Navinta
DMS Pharmaceutical
Shanghai Furen Medicine
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nicardipine Hydrochloride Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nicardipine Hydrochloride Injection market by identifying its various subsegments.
Focuses on the key global Nicardipine Hydrochloride Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nicardipine Hydrochloride Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nicardipine Hydrochloride Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nicardipine Hydrochloride Injection Consumption 2015-2025
2.1.2 Nicardipine Hydrochloride Injection Consumption CAGR by Region
2.2 Nicardipine Hydrochloride Injection Segment by Type
2.2.1 20 mg / 200 mL
2.2.2 40 mg / 200 mL
2.3 Nicardipine Hydrochloride Injection Consumption by Type
2.3.1 Global Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
2.3.2 Global Nicardipine Hydrochloride Injection Revenue and Market Share by Type (2015-2020)
2.3.3 Global Nicardipine Hydrochloride Injection Sale Price by Type (2015-2020)
2.4 Nicardipine Hydrochloride Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Recovery Center
2.5 Nicardipine Hydrochloride Injection Consumption by Application
2.5.1 Global Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
2.5.2 Global Nicardipine Hydrochloride Injection Value and Market Share by Type (2015-2020)
2.5.3 Global Nicardipine Hydrochloride Injection Sale Price by Type (2015-2020)
3 Global Nicardipine Hydrochloride Injection by Company
3.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Company
3.1.1 Global Nicardipine Hydrochloride Injection Sales by Company (2018-2020)
3.1.2 Global Nicardipine Hydrochloride Injection Sales Market Share by Company (2018-2020)
3.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Company
3.2.1 Global Nicardipine Hydrochloride Injection Revenue by Company (2018-2020)
3.2.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Company (2018-2020)
3.3 Global Nicardipine Hydrochloride Injection Sale Price by Company
3.4 Global Nicardipine Hydrochloride Injection Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Nicardipine Hydrochloride Injection Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Nicardipine Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Nicardipine Hydrochloride Injection by Regions
4.1 Nicardipine Hydrochloride Injection by Regions
4.2 Americas Nicardipine Hydrochloride Injection Consumption Growth
4.3 APAC Nicardipine Hydrochloride Injection Consumption Growth
4.4 Europe Nicardipine Hydrochloride Injection Consumption Growth
4.5 Middle East & Africa Nicardipine Hydrochloride Injection Consumption Growth
5 Americas
5.1 Americas Nicardipine Hydrochloride Injection Consumption by Countries
5.1.1 Americas Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020)
5.1.2 Americas Nicardipine Hydrochloride Injection Value by Countries (2015-2020)
5.2 Americas Nicardipine Hydrochloride Injection Consumption by Type
5.3 Americas Nicardipine Hydrochloride Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nicardipine Hydrochloride Injection Consumption by Regions
6.1.1 APAC Nicardipine Hydrochloride Injection Consumption by Regions (2015-2020)
6.1.2 APAC Nicardipine Hydrochloride Injection Value by Regions (2015-2020)
6.2 APAC Nicardipine Hydrochloride Injection Consumption by Type
6.3 APAC Nicardipine Hydrochloride Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nicardipine Hydrochloride Injection by Countries
7.1.1 Europe Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020)
7.1.2 Europe Nicardipine Hydrochloride Injection Value by Countries (2015-2020)
7.2 Europe Nicardipine Hydrochloride Injection Consumption by Type
7.3 Europe Nicardipine Hydrochloride Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nicardipine Hydrochloride Injection by Countries
8.1.1 Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Nicardipine Hydrochloride Injection Value by Countries (2015-2020)
8.2 Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Type
8.3 Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nicardipine Hydrochloride Injection Distributors
10.3 Nicardipine Hydrochloride Injection Customer
11 Global Nicardipine Hydrochloride Injection Market Forecast
11.1 Global Nicardipine Hydrochloride Injection Consumption Forecast (2021-2025)
11.2 Global Nicardipine Hydrochloride Injection Forecast by Regions
11.2.1 Global Nicardipine Hydrochloride Injection Forecast by Regions (2021-2025)
11.2.2 Global Nicardipine Hydrochloride Injection Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nicardipine Hydrochloride Injection Forecast by Type
11.8 Global Nicardipine Hydrochloride Injection Forecast by Application
12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Nicardipine Hydrochloride Injection Product Offered
12.1.3 Baxter Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 Teva
12.2.1 Company Information
12.2.2 Nicardipine Hydrochloride Injection Product Offered
12.2.3 Teva Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Teva Latest Developments
12.3 Hikma
12.3.1 Company Information
12.3.2 Nicardipine Hydrochloride Injection Product Offered
12.3.3 Hikma Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Hikma Latest Developments
12.4 Sun Pharma
12.4.1 Company Information
12.4.2 Nicardipine Hydrochloride Injection Product Offered
12.4.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sun Pharma Latest Developments
12.5 Chiesi
12.5.1 Company Information
12.5.2 Nicardipine Hydrochloride Injection Product Offered
12.5.3 Chiesi Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Chiesi Latest Developments
12.6 Mylan
12.6.1 Company Information
12.6.2 Nicardipine Hydrochloride Injection Product Offered
12.6.3 Mylan Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Sandoz
12.7.1 Company Information
12.7.2 Nicardipine Hydrochloride Injection Product Offered
12.7.3 Sandoz Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sandoz Latest Developments
12.8 Wockhardt
12.8.1 Company Information
12.8.2 Nicardipine Hydrochloride Injection Product Offered
12.8.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Wockhardt Latest Developments
12.9 Navinta
12.9.1 Company Information
12.9.2 Nicardipine Hydrochloride Injection Product Offered
12.9.3 Navinta Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Navinta Latest Developments
12.10 DMS Pharmaceutical
12.10.1 Company Information
12.10.2 Nicardipine Hydrochloride Injection Product Offered
12.10.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 DMS Pharmaceutical Latest Developments
12.11 Shanghai Furen Medicine
12.11.1 Company Information
12.11.2 Nicardipine Hydrochloride Injection Product Offered
12.11.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shanghai Furen Medicine Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nicardipine Hydrochloride Injection Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 20 mg / 200 mL
Table 5. Major Players of 40 mg / 200 mL
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 8. Global Nicardipine Hydrochloride Injection Revenue by Type (2015-2020) ($ million)
Table 9. Global Nicardipine Hydrochloride Injection Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Nicardipine Hydrochloride Injection Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 13. Global Nicardipine Hydrochloride Injection Value by Application (2015-2020)
Table 14. Global Nicardipine Hydrochloride Injection Value Market Share by Application (2015-2020)
Table 15. Global Nicardipine Hydrochloride Injection Sale Price by Application (2015-2020)
Table 16. Global Nicardipine Hydrochloride Injection Sales by Company (2017-2019) (K Units)
Table 17. Global Nicardipine Hydrochloride Injection Sales Market Share by Company (2017-2019)
Table 18. Global Nicardipine Hydrochloride Injection Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company (2017-2019)
Table 20. Global Nicardipine Hydrochloride Injection Sale Price by Company (2017-2019)
Table 21. Global Nicardipine Hydrochloride Injection Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Nicardipine Hydrochloride Injection Products Offered
Table 23. Nicardipine Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Nicardipine Hydrochloride Injection Consumption by Regions 2015-2020 (K Units)
Table 25. Global Nicardipine Hydrochloride Injection Consumption Market Share by Regions 2015-2020
Table 26. Global Nicardipine Hydrochloride Injection Value by Regions 2015-2020 ($ Millions)
Table 27. Global Nicardipine Hydrochloride Injection Value Market Share by Regions 2015-2020
Table 28. Americas Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 30. Americas Nicardipine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Nicardipine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 32. Americas Nicardipine Hydrochloride Injection Consumption by Type (2015-2020) (K Units)
Table 33. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 34. Americas Nicardipine Hydrochloride Injection Consumption by Application (2015-2020) (K Units)
Table 35. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 36. APAC Nicardipine Hydrochloride Injection Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Regions (2015-2020)
Table 38. APAC Nicardipine Hydrochloride Injection Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Nicardipine Hydrochloride Injection Value Market Share by Regions (2015-2020)
Table 40. APAC Nicardipine Hydrochloride Injection Consumption by Type (2015-2020) (K Units)
Table 41. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 42. APAC Nicardipine Hydrochloride Injection Consumption by Application (2015-2020) (K Units)
Table 43. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 44. Europe Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 46. Europe Nicardipine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Nicardipine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 48. Europe Nicardipine Hydrochloride Injection Consumption by Type (2015-2020) (K Units)
Table 49. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 50. Europe Nicardipine Hydrochloride Injection Consumption by Application (2015-2020) (K Units)
Table 51. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Nicardipine Hydrochloride Injection Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Nicardipine Hydrochloride Injection Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Nicardipine Hydrochloride Injection Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Table 60. Nicardipine Hydrochloride Injection Distributors List
Table 61. Nicardipine Hydrochloride Injection Customer List
Table 62. Global Nicardipine Hydrochloride Injection Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Nicardipine Hydrochloride Injection Consumption Market Forecast by Regions
Table 64. Global Nicardipine Hydrochloride Injection Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Nicardipine Hydrochloride Injection Value Market Share Forecast by Regions
Table 66. Global Nicardipine Hydrochloride Injection Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Nicardipine Hydrochloride Injection Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Nicardipine Hydrochloride Injection Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Nicardipine Hydrochloride Injection Value Market Share Forecast by Type (2021-2025)
Table 70. Global Nicardipine Hydrochloride Injection Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Nicardipine Hydrochloride Injection Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Nicardipine Hydrochloride Injection Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Nicardipine Hydrochloride Injection Value Market Share Forecast by Application (2021-2025)
Table 74. Baxter Product Offered
Table 75. Baxter Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. Baxter Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Product Offered
Table 80. Teva Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Teva Main Business
Table 82. Teva Latest Developments
Table 83. Teva Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Hikma Product Offered
Table 85. Hikma Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Hikma Main Business
Table 87. Hikma Latest Developments
Table 88. Hikma Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharma Product Offered
Table 90. Sun Pharma Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Sun Pharma Main Business
Table 92. Sun Pharma Latest Developments
Table 93. Sun Pharma Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Chiesi Product Offered
Table 95. Chiesi Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Chiesi Main Business
Table 97. Chiesi Latest Developments
Table 98. Chiesi Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Product Offered
Table 100. Mylan Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Mylan Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Product Offered
Table 105. Sandoz Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Sandoz Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. Wockhardt Product Offered
Table 110. Wockhardt Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Wockhardt Main Business
Table 112. Wockhardt Latest Developments
Table 113. Wockhardt Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Navinta Product Offered
Table 115. Navinta Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Navinta Main Business
Table 117. Navinta Latest Developments
Table 118. Navinta Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. DMS Pharmaceutical Product Offered
Table 120. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. DMS Pharmaceutical Main Business
Table 122. DMS Pharmaceutical Latest Developments
Table 123. DMS Pharmaceutical Basic Information, Company Total Revenue (in $ million), Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Furen Medicine Product Offered
Table 125. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. Shanghai Furen Medicine Main Business
Table 127. Shanghai Furen Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai Furen Medicine Latest Developments
List of Figures
Figure 1. Picture of Nicardipine Hydrochloride Injection
Figure 2. Nicardipine Hydrochloride Injection Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Nicardipine Hydrochloride Injection Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Nicardipine Hydrochloride Injection Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 20 mg / 200 mL
Figure 7. Product Picture of 40 mg / 200 mL
Figure 8. Global Nicardipine Hydrochloride Injection Consumption Market Share by Type (2015-2020)
Figure 9. Global Nicardipine Hydrochloride Injection Value Market Share by Type (2015-2020)
Figure 10. Nicardipine Hydrochloride Injection Consumed in Hospital
Figure 11. Global Nicardipine Hydrochloride Injection Market: Hospital (2015-2020) (K Units)
Figure 12. Global Nicardipine Hydrochloride Injection Market: Hospital (2015-2020) ($ Millions)
Figure 13. Nicardipine Hydrochloride Injection Consumed in Clinic
Figure 14. Global Nicardipine Hydrochloride Injection Market: Clinic (2015-2020) (K Units)
Figure 15. Global Nicardipine Hydrochloride Injection Market: Clinic (2015-2020) ($ Millions)
Figure 16. Nicardipine Hydrochloride Injection Consumed in Recovery Center
Figure 17. Global Nicardipine Hydrochloride Injection Market: Recovery Center (2015-2020) (K Units)
Figure 18. Global Nicardipine Hydrochloride Injection Market: Recovery Center (2015-2020) ($ Millions)
Figure 19. Global Nicardipine Hydrochloride Injection Consumption Market Share by Application (2015-2020)
Figure 20. Global Nicardipine Hydrochloride Injection Value Market Share by Application (2015-2020)
Figure 21. Global Nicardipine Hydrochloride Injection Sales Market Share by Company in 2017
Figure 22. Global Nicardipine Hydrochloride Injection Sales Market Share by Company in 2019
Figure 23. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company in 2017
Figure 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company in 2019
Figure 25. Global Nicardipine Hydrochloride Injection Sale Price by Company in 2019
Figure 26. Global Nicardipine Hydrochloride Injection Consumption Market Share by Regions 2015-2020
Figure 27. Global Nicardipine Hydrochloride Injection Value Market Share by Regions 2015-2020
Figure 28. Americas Nicardipine Hydrochloride Injection Consumption 2015-2020 (K Units)
Figure 29. Americas Nicardipine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 30. APAC Nicardipine Hydrochloride Injection Consumption 2015-2020 (K Units)
Figure 31. APAC Nicardipine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 32. Europe Nicardipine Hydrochloride Injection Consumption 2015-2020 (K Units)
Figure 33. Europe Nicardipine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Nicardipine Hydrochloride Injection Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Nicardipine Hydrochloride Injection Value 2015-2020 ($ Millions)
Figure 36. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 37. Americas Nicardipine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 38. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 39. Americas Nicardipine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 40. United States Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 41. United States Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 47. APAC Nicardipine Hydrochloride Injection Value Market Share by Regions in 2019
Figure 48. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 49. APAC Nicardipine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 50. China Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 51. China Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 58. India Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 59. India Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 63. Europe Nicardipine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 64. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 65. Europe Nicardipine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 66. Germany Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 68. France Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 69. France Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 70. UK Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 71. UK Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Nicardipine Hydrochloride Injection Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Nicardipine Hydrochloride Injection Consumption Market Share by Application in 2019
Figure 80. Egypt Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Nicardipine Hydrochloride Injection Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Nicardipine Hydrochloride Injection Value Growth 2015-2020 ($ Millions)
Figure 90. Global Nicardipine Hydrochloride Injection Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Nicardipine Hydrochloride Injection Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 93. Americas Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 94. APAC Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 95. APAC Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 96. Europe Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 97. Europe Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 100. United States Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 101. United States Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 102. Canada Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 103. Canada Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 104. Mexico Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 105. Mexico Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 106. Brazil Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 107. Brazil Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 108. China Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 109. China Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 110. Japan Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 111. Japan Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 112. Korea Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 113. Korea Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 116. India Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 117. India Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 118. Australia Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 119. Australia Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 120. Germany Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 121. Germany Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 122. France Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 123. France Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 124. UK Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 125. UK Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 126. Italy Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 127. Italy Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 128. Russia Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 129. Russia Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 130. Spain Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 131. Spain Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 132. Egypt Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 133. Egypt Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 134. South Africa Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 135. South Africa Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 136. Israel Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 137. Israel Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 138. Turkey Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 139. Turkey Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Nicardipine Hydrochloride Injection Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Nicardipine Hydrochloride Injection Value 2021-2025 ($ Millions)
Figure 142. Baxter Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 143. Teva Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 144. Hikma Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 145. Sun Pharma Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 146. Chiesi Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 147. Mylan Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 148. Sandoz Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 149. Wockhardt Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 150. Navinta Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 151. DMS Pharmaceutical Nicardipine Hydrochloride Injection Market Share (2018-2020)
Figure 152. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets